These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Immunoparesis and outcome in measles. Coovadia HM; Wesley A; Brain P; Henderson LG; Hallett AF; Vos GH Lancet; 1977 Mar; 1(8012):619-21. PubMed ID: 66426 [TBL] [Abstract][Full Text] [Related]
8. [The clinicoimmunological evaluation of the use of timogeksin in different forms of measles]. Ershova IB Lik Sprava; 1997; (6):147-51. PubMed ID: 9589963 [TBL] [Abstract][Full Text] [Related]
9. A controlled trial of treatment of acquired immunodeficiency in severe measles with thymic humoral factor. Beatty DW; Handzel ZT; Pecht M; Ryder CR; Hughes J; McCabe K; Trainin N Clin Exp Immunol; 1984 Jun; 56(3):479-85. PubMed ID: 6378450 [TBL] [Abstract][Full Text] [Related]
10. Immunological studies in children with chronic pulmonary infection. Wesley AG; Paren MA; Schonland M; Henderson L; O'Dowd PB S Afr Med J; 1976 Mar; 50(12):465-8. PubMed ID: 1273712 [TBL] [Abstract][Full Text] [Related]
12. Application of live attenuated measles and mumps vaccines in children with acute leukemia. Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040 [TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines. Okada H; Sato TA; Katayama A; Higuchi K; Shichijo K; Tsuchiya T; Takayama N; Takeuchi Y; Abe T; Okabe N; Tashiro M Arch Virol; 2001; 146(5):859-74. PubMed ID: 11448026 [TBL] [Abstract][Full Text] [Related]
14. Current concepts. The biology of measles in African children. Scheifele DW; Forbes CE East Afr Med J; 1973 Mar; 50(3):168-73. PubMed ID: 4724680 [No Abstract] [Full Text] [Related]
16. Immunity to measles in malnourished children. Whittle HC; Mee J; Werblinska J; Yakubu A; Onuora C; Gomwalk N Clin Exp Immunol; 1980 Oct; 42(1):144-51. PubMed ID: 6161724 [TBL] [Abstract][Full Text] [Related]
17. Further predictive indices of clinical severity of measles. Wesley AG; Coovadia HM; Kiepiela P S Afr Med J; 1982 May; 61(18):663-5. PubMed ID: 7079863 [TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory T cells in measles. The relationship between reduced lymphocyte proliferative response to PHA and increased proportion of circulating suppressor-cytotoxic T cells. Bertotto A; Rambotti A; Gentilini F; Stefanelli M; Zucchetti P; Vaccaro R Microbiologica; 1984 Jan; 7(1):21-7. PubMed ID: 6233473 [TBL] [Abstract][Full Text] [Related]
19. Humoral immune response in children with measles. Wesley AG; Hallett AF; Smythe PM S Afr Med J; 1975 Jan; 49(3):69-72. PubMed ID: 1114409 [TBL] [Abstract][Full Text] [Related]
20. Immunity to and infant mortality from measles. Coovadia HM; Kiepiela P; Wesley AG S Afr Med J; 1984 Jun; 65(23):918-21. PubMed ID: 6729634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]